| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/18/2004 | EP1447098A2 Therapeutic inhibitor of vascular smooth muscle cells |
| 08/18/2004 | EP1447096A1 Remedies for urinary frequency |
| 08/18/2004 | EP1447095A1 Preventives and/or remedies for post-transplant arteriosclerosis as rejection of organ transplant |
| 08/18/2004 | EP1447094A1 Remedies for pruritus |
| 08/18/2004 | EP1447093A1 Inhibition of the CD95 ligand/receptor system for the treatment of neurological disorders and injuries |
| 08/18/2004 | EP1447090A2 Use of hyaluronidase for preventing and treating cardiovascular diseases |
| 08/18/2004 | EP1447085A1 Agent controlling the production of osteoclast formation regulator and method of screening substance capable of controlling the production of osteoclast formation regulator |
| 08/18/2004 | EP1447084A1 Freeze-dried pharmaceutical preparation |
| 08/18/2004 | EP1447083A1 Preventives/remedies for viral infection |
| 08/18/2004 | EP1447013A1 Method for reducing the glycemic index of food |
| 08/18/2004 | EP1447012A1 Nutritional supplement to treat macular degeneration |
| 08/18/2004 | EP1446733A2 Glycosylphosphatidylinositol containing polypeptides |
| 08/18/2004 | EP1446659A2 Systems and methods for the generation of crystalline polymorphs |
| 08/18/2004 | EP1446413A1 Synthesis of 2-aralkoxy adenosines and 2-alkoxyadenosines |
| 08/18/2004 | EP1446412A2 Novel lna compositions and uses thereof |
| 08/18/2004 | EP1446411A1 Acarbose purification process |
| 08/18/2004 | EP1446407A2 (pyrido/thieno)-(f)-oxazepin-5-one derivatives as positive modulators of the ampa receptor |
| 08/18/2004 | EP1446405A2 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 08/18/2004 | EP1446404A1 Rosiglitazone edisylates and their use as antidiabetics |
| 08/18/2004 | EP1446403A1 Aryl substituted oxazolidinones with antibacterial activity |
| 08/18/2004 | EP1446402A1 2-amino-4-heteroarylethyl thiazoline derivatives and their use an inhibitors of inducible no-synthase |
| 08/18/2004 | EP1446401A2 C-5 modified indazolylpyrrolotriazines |
| 08/18/2004 | EP1446400A1 Piperidine derivatives, process for preparation thereof, and pharmaceutical composition for alzheimer's disease containing the same |
| 08/18/2004 | EP1446399A1 Piperazine derivatives having sst1 antagonistic activity |
| 08/18/2004 | EP1446397A1 Novel mandelate salts of substituted tetracyclic tetrahydrofuran derivatives |
| 08/18/2004 | EP1446396A1 Methods for treating depression and other cns disorders using enantiomerically enriched desmethyl- and didesmethyl-metabolites of citalopram |
| 08/18/2004 | EP1446394A1 NOVEL 1,2,4−THIADIAZOLE DERIVATIVES AS MELANOCORTIN RECEPTOR MODULATORS |
| 08/18/2004 | EP1446393A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase |
| 08/18/2004 | EP1446391A2 Preparation and use of carbohydrate-based ring structures with antimicrobial and cytostatic activity |
| 08/18/2004 | EP1446388A1 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors |
| 08/18/2004 | EP1446386A1 Benzimidazol- or indol-aminoacetonitrile derivatives for parasite control |
| 08/18/2004 | EP1446385A1 Preparation and use of substituted imidazoles |
| 08/18/2004 | EP1446384A1 Polymorphous form of rimonabant, preparation method and pharmaceutical compositions containing same |
| 08/18/2004 | EP1446383A1 Monohydroxycarbamazepine for use in the preparation of a medicament for the treatment of affective and attention disorder and neuropathic pain |
| 08/18/2004 | EP1446382A1 Anthranilic acid amides and their use as vegf receptor tyrosine kinase inhibitors |
| 08/18/2004 | EP1446381A1 Anthranilic acid amides and pharmaceutical use thereof |
| 08/18/2004 | EP1446380A1 Formoterol tartrate process and polymorph |
| 08/18/2004 | EP1446379A1 Aryl aniline beta-2 adrenergic receptor agonists |
| 08/18/2004 | EP1446375A1 Dihalogenpropene compounds, method for the production thereof, agents containing said compounds and the use thereof as pest control agents |
| 08/18/2004 | EP1446170A1 Medical devices having antimicrobial coatings thereon |
| 08/18/2004 | EP1446167A2 Treating canker sores with patches to speed healing and relieve pain |
| 08/18/2004 | EP1446162A2 Combination motif immune stimulatory oligonucleotides with improved activity |
| 08/18/2004 | EP1446161A2 Medicinal combination of biguanine (metformin) and arginine |
| 08/18/2004 | EP1446160A1 Aspirin-containing transdermal pharmaceutical composition for the treatment of calcification |
| 08/18/2004 | EP1446159A2 Immunotherapy for reversing immune suppression |
| 08/18/2004 | EP1446148A1 Pharmaceutical composition comprising a factor vii polypeptide and epsilon-aminocapronic acid |
| 08/18/2004 | EP1446147A1 Pharmaceutical composition comprising factor vii polypeptides and tranexamic acid |
| 08/18/2004 | EP1446144A2 The use of leptin in infertility |
| 08/18/2004 | EP1446140A2 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (tfpi) |
| 08/18/2004 | EP1446138A2 Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi) |
| 08/18/2004 | EP1446136A2 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 08/18/2004 | EP1446132A2 Antidiabetic 2-substituted-5'-o- (1-boranotriphosphate) adenosine derivatives |
| 08/18/2004 | EP1446131A1 Use of specific dose of fondaparinux sodium for the treatment of acs |
| 08/18/2004 | EP1446129A2 Polynucleotide therapy |
| 08/18/2004 | EP1446128A1 Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy |
| 08/18/2004 | EP1446127A1 Triazepine derivatives as neurotrophic agents |
| 08/18/2004 | EP1446126A1 Coated particulate cefuroxime axetil compositions |
| 08/18/2004 | EP1446125A1 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity |
| 08/18/2004 | EP1446124A1 Combination therapy comprising zd6474 and a taxane |
| 08/18/2004 | EP1446123A1 Rosuvastatin in pre demented states |
| 08/18/2004 | EP1446122A1 Use of flibanserin in the treatment of sexual disorders |
| 08/18/2004 | EP1446121A2 Diindolylmethane for the treatment of hpv infection |
| 08/18/2004 | EP1446119A2 Compositions comprising ipatropium and xylometazoline for treatment of the common cold |
| 08/18/2004 | EP1446118A1 Oral dosage form of a sulfonamide prodrug such as parecoxib |
| 08/18/2004 | EP1446117A2 Treatment of acute myeloid leukemia with indolinone compounds |
| 08/18/2004 | EP1446116A1 Inhibitors of dipeptidyl peptidase iv |
| 08/18/2004 | EP1446115A2 Cyanoalkylamino derivatives as protease inhibitors |
| 08/18/2004 | EP1446114A1 Compositions and methods for treating osteoporosis |
| 08/18/2004 | EP1446113A2 Compounds and methods for treating transplant rejection |
| 08/18/2004 | EP1446112A1 USE OF GLUTAMATE, GLUTAMATE DERIVATIVES OR METABOLITES, GLUTAMATE ANALOGUES OR MIXTURES THEREOF FOR THE MANUFACTURE OF A COMPOSITION FOR THE TREATMENT OF OSTEOPOROSIS |
| 08/18/2004 | EP1446111A1 Materials and methods for treatment of neurological disorders involving overactivation of glutamatergic ionotropic receptors |
| 08/18/2004 | EP1446110A2 Organosulfur inhibitors of tyrosine phosphatases |
| 08/18/2004 | EP1446109A1 Methods and compositions for use of (s)-bisoprolol |
| 08/18/2004 | EP1446108A2 Methods and reagents for the control of infestations of parasites |
| 08/18/2004 | EP1446107A1 Process for the preparation of tablets comprising s-adenosylmethionine |
| 08/18/2004 | EP1446106A2 Optimal polymer mixtures for gastric retentive tablets |
| 08/18/2004 | EP1446104A1 Spray drying methods and compositions thereof |
| 08/18/2004 | EP1446103A2 Injectable compositions for the controlled delivery of pharmacologically active compound |
| 08/18/2004 | EP1446102A1 Delivery of caffeine through an inhalation route |
| 08/18/2004 | EP1446100A2 Injectable depot compositions and uses thereof |
| 08/18/2004 | EP1446096A1 Topical compositions containing enzymes stabilised with inhibitors |
| 08/18/2004 | EP1446095A1 Skin preparation comprising a tocopherol derivative for external application |
| 08/18/2004 | EP1446094A1 Cosmetic and dermatological anti-uv formulations containing hydroxybenzophenone and triazine and/or benzotriazol derivatives |
| 08/18/2004 | EP1446088A2 Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process |
| 08/18/2004 | EP1446087A2 Method for treating non-neuropathic pain |
| 08/18/2004 | EP1446086A1 Compositions containing oils having a specific gravity higher than the specific gravity of water |
| 08/18/2004 | EP1446045A2 An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
| 08/18/2004 | EP1446022A1 Oilseed processing |
| 08/18/2004 | EP1446012A1 Combination bacteriolytic therapy for the treatment of tumors |
| 08/18/2004 | EP1446010A2 Stabilized azithromycin compositions |
| 08/18/2004 | EP1446009A2 Compounds useful in the treatment of anthrax |
| 08/18/2004 | EP1446008A2 Compositions and methods for controlled release |
| 08/18/2004 | EP1395273A4 Targeted delivery of drugs for the treatment of viral infections |
| 08/18/2004 | EP1370263B1 Antibiotic pharmaceutical composition with lysergol as bio-enhancer and method of treatment |
| 08/18/2004 | EP1370210A4 Cholesterol-lowering agents as treatment for psychological and cognitive disorders |
| 08/18/2004 | EP1345951B1 A substance or composition for the treatment of cancer |
| 08/18/2004 | EP1345585A4 Compositions for prevention and alleviation of skin wrinkles |
| 08/18/2004 | EP1343434A4 Methods for contemporaneous administration of levamisole and 5-fluorouracil |
| 08/18/2004 | EP1315504B1 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications |
| 08/18/2004 | EP1313475A4 Anti-cancer composition composed of anti-cancer and anti-malarial drugs |